Cargando…
Impact of COX2 genotype, ER status and body constitution on risk of early events in different treatment groups of breast cancer patients
The COX2 rs5277 (306G>C) polymorphism has been associated with inflammation-associated cancers. In breast cancer, tumor COX-2 expression has been associated with increased estrogen levels in estrogen receptor (ER)-positive and activated Akt-pathway in ER-negative tumors. Our study investigated th...
Autores principales: | Markkula, Andrea, Simonsson, Maria, Rosendahl, Ann H, Gaber, Alexander, Ingvar, Christian, Rose, Carsten, Jernström, Helena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225481/ https://www.ncbi.nlm.nih.gov/pubmed/24599585 http://dx.doi.org/10.1002/ijc.28831 |
Ejemplares similares
-
Impacts of smoking on endocrine treatment response in a prospective breast cancer cohort
por: Persson, Mia, et al.
Publicado: (2016) -
IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort
por: Markkula, Andrea, et al.
Publicado: (2014) -
Pre- and postoperative alcohol consumption in breast cancer patients: impact on early events
por: Simonsson, Maria, et al.
Publicado: (2014) -
Body Mass Index Influences the Prognostic Impact of Combined Nuclear Insulin Receptor and Estrogen Receptor Expression in Primary Breast Cancer
por: Björner, Sofie, et al.
Publicado: (2017) -
Combined and individual tumor-specific expression of insulin-like growth factor-I receptor, insulin receptor and phospho-insulin-like growth factor-I receptor/insulin receptor in primary breast cancer: Implications for prognosis in different treatment groups
por: Björner, Sofie, et al.
Publicado: (2016)